Riskpilot← Back to searchSign inGet full accessRaybow Europe Incorporated ApS
APSIn liquidationCVR 40101659Johannevej 20Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20181 employees
Revenue 2024
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2024
—
1 employees
| Revenue | — | — |
| EBITDA | — | — |
| Net profit | — | — |
| Total assets | DKK 0 | -100% |
| Equity | — | — |
| Employees | 1 | — |
Legal name
Raybow Europe Incorporated ApS
CVR number
40101659
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
17. december 2018
Share capital
DKK 33.077.500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Johannevej 20
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4.343 | 6.766 | 5.471 | 5.036 | — |
| Staff expenses | -3.998 | -6.244 | -4.993 | -4.630 | -0 |
| EBITDA | 345 | 522 | 478 | 406 | — |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 345 | 522 | 478 | 406 | — |
| Net financials | -25 | -24 | -36 | 6 | 0 |
| Profit before tax | 320 | 498 | 441 | 412 | — |
| Tax | -531 | 111 | 99 | 92 | -0 |
| Net profit | 850 | 387 | 342 | 320 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 31.630 | 33.424 | 33.223 | 32.907 | 0 |
| Equity | 31.196 | 31.583 | 31.925 | 32.245 | — |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 435 | 1.841 | 1.298 | 661 | 0 |
| Total debt | 435 | 1.841 | 1.298 | 661 | 0 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
PH Chief Executive Officer | Chief Executive Officer | 2018 – 2024 |
JK Unofficial title | Unofficial title | 2024 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
BW | Chairman | 2018 – 2024 |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Raybow Europe Incorporated ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Halkjær-Knudsen | Chief Executive Officer | 0 companies |
| Jakob Kristensen | Unofficial title | 0 companies |
| Bin Wang | Chairman | 0 companies |